OPUS GENETICS INC. -
1.1000
25-November-24 16:45:01
15 minutes delayed
Stocks
+0.0900
+8.91%
Today's range
1.0200 - 1.1200
ISIN
N/A
Source
NASDAQ
-
Ocuphire Pharma to Present at the MicroCap Rodeo Windy City Roundup 2022 Conference
07 Oct 2022 07:00:00 By Nasdaq GlobeNewswire
-
Ocuphire Pharma Hosting Key Opinion Leader Event on Oral APX3330 for Diabetic Eye Disease
06 Oct 2022 09:27:49 By Nasdaq GlobeNewswire
-
Ocuphire Expands Medical Advisory Board with Seven New KOLs and Strengthens Leadership Team
29 Sep 2022 08:00:01 By Nasdaq GlobeNewswire
-
15 Sep 2022 07:00:01 By Nasdaq GlobeNewswire
-
Ocuphire Pharma Receives PDFUA Fee Waiver for Nyxol New Drug Application from FDA
12 Sep 2022 08:00:01 By Nasdaq GlobeNewswire
-
08 Sep 2022 08:00:01 By Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at The H.C. Wainwright 24th Annual Global Investment Conference
06 Sep 2022 09:00:01 By Nasdaq GlobeNewswire
-
12 Aug 2022 07:00:00 By Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Upcoming Presentations at Two Conferences in August
08 Aug 2022 07:00:00 By Nasdaq GlobeNewswire
-
03 Aug 2022 08:00:01 By Nasdaq GlobeNewswire
-
07 Jul 2022 08:00:01 By Nasdaq GlobeNewswire
-
29 Jun 2022 09:00:37 By Nasdaq GlobeNewswire
-
08 Jun 2022 08:00:01 By Nasdaq GlobeNewswire
-
19 May 2022 07:00:00 By Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for First Quarter 2022 and Provides Corporate Update
13 May 2022 08:00:01 By Nasdaq GlobeNewswire
-
11 May 2022 08:00:02 By Nasdaq GlobeNewswire
-
Ocuphire Announces Upcoming Clinical Presentations at ARVO 2022 Medical Meeting and MODLive! 2022
26 Apr 2022 09:00:02 By Nasdaq GlobeNewswire
-
19 Apr 2022 08:00:01 By Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at Wet AMD & DME Drug Development Summit in Boston, MA
06 Apr 2022 08:00:01 By Nasdaq GlobeNewswire